
The mesenchymal stem cells used in regenerative medicine are sourced from donated birth tissue collected after healthy, full-term C-section deliveries. This may include tissue associated with the umbilical cord and other perinatal sources that would otherwise be discarded after birth.
The collection process is performed only after the baby has been safely delivered and does not involve abortion or harm to the mother or child.
The donated tissue is then processed and screened according to established laboratory and safety protocols before it may be used for regenerative medicine applications.
Why C-section collection?
C-section delivery allows the birth tissue to be collected in a controlled surgical environment, helping reduce exposure to contaminants that may be present during vaginal delivery.
